About
Our Company
Leadership
Advisors
Careers
Contact
Focus
IBAL
Research
Anticancer
Antimicrobial
Prevention
Pipeline
API Developments
Anti-inflammatory
Oncology
Ion Gel ZCM-25
Infections
Wound Healing
Skin Cancers
Preclinical
Clinical
Media
News
Partners
Investors
Contact
Español
Search for:
June 15, 2014
ION-ZC1 – Topical Skin Irritation on Humans
Clinical
No irritation detected on 10 human subjects using a cream-based formula of ION-ZC1 at 10% concentration.
Completed 2014 by Cencon Labs, Mexico.
Related Publications
Ion Gel ZCM-25® Clinical Phase 2 Human Dosing & Efficacy Study
February 15, 2021
Ion Gel ZCM-25® Clinical Phase 1 Human Safety Study
October 5, 2020
close
angle-right
magnifier
cross
menu-circle